DENISE NEBGEN to Ovarian Neoplasms
This is a "connection" page, showing publications DENISE NEBGEN has written about Ovarian Neoplasms.
Connection Strength
0.834
-
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations. BJOG. 2023 11; 130(12):1437-1450.
Score: 0.281
-
Novel Approaches to Ovarian Cancer Screening. Curr Oncol Rep. 2019 07 26; 21(8):75.
Score: 0.217
-
Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations. Gynecol Oncol. 2018 07; 150(1):79-84.
Score: 0.199
-
Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial. JAMA Oncol. 2023 11 01; 9(11):1547-1555.
Score: 0.073
-
MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing. BMC Cancer. 2019 Jul 02; 19(1):648.
Score: 0.054
-
Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015 Jan 15; 121(2):269-75.
Score: 0.010